Fosun Pharma Archives | Be Korea-savvy

Neovii and Fosun Pharma Enter Into an Exclusive Agreement

ST. GALLEN, Switzerland, Sept. 7 (Korea Bizwire) — Neovii Pharmaceuticals AG (“Neovii”), a Swiss based global specialty-care biopharmaceutical company, and Shanghai Fosun Pharmaceutical Industry Development Co. Ltd (“Fosun Pharma Industry”), a subsidiary of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (“Fosun Pharma”, Stock Code: 600196.SH, 02196.HK), a global pharmaceutical and healthcare industry group deep-rooted in China, [...]

Helsinn and Fosun Pharma Sign Exclusive License and Distribution Agreements for Aloxi®, Akynzeo® Oral, NEPA IV and Anamorelin in Mainland China, Hong Kong SAR and Macau SAR

Lugano, Switzerland – Shanghai, China, Oct. 12 (Korea Bizwire) – Helsinn Group (“Helsinn”), a Swiss Biopharmaceutical Group with an innovative R&D pipeline in cancer supportive care and oncology therapeutics, strategically investing in a fully integrated targeted therapy structure to develop, manufacture and commercialize small molecules in precision medicine with higher market potential, and Fosun Pharmaceutical A.G., a corporation organised [...]